Fujifilm holdings corp, Multinational conglomerate company

The production of the Favipiravir antiviral drug that will be used in COVID-19 vaccines will commence in December, the press service of the Russian pharmaceutical company Promomed told Sputnik."Production will start in December," a Promomed spokesperson said.On November 12, the drug was registered as a means to treat COVID-19 through vaccinations. It will be put into circulation for the next 5 years.The drug was approved by Russia's health ministry to be developed into pills in 2020 and sold under the name of Areplivir to treat COVID-19 infections. Its chemical base was initially developed by Japanese company Fujifilm Holdings Corp as an influenza drug. (ANI/Sputnik)( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Salman Khan

Fujifilm Holdings CorpFOLLOW

Fujifilm holdings corp, Latest News

Technology :Fujifilm introduces new film-digital hybrid Instax Mini Evo camera

The Japanese camera maker Fujifilm has recently announced a new digital camera titled the Instax Mini Evo, that prints to Instax Mini film. ...

International :Russia-developed COVID-19 drug to start production in December- Firm to Sputnik

The production of the Favipiravir antiviral drug that will be used in COVID-19 vaccines will commence in December, the press service of the Russian pharmaceutical company Promomed told Sputnik. ...